Processed in 1–3 business days in insulated, blind-labelled packaging.
HPLC purity, mass-spec identity, measured vial mass, heavy metals and endotoxin are published for each lot as its laboratory report is received.
The HPLC purity shown for your exact lot is the measured result from its report — never a rounded-up marketing number.
Live chat, tickets and VIP concierge for order, COA and handling questions.
BELIGAS PEPTIDES supplies synthetic research peptides to universities, contract research organisations and independent laboratories in the United States, United Kingdom, Canada and Australia. Every compound is sold strictly for in-vitro research and is organised by research function — metabolic, tissue repair, growth-hormone axis, neuroscience, dermal and endocrine models — so you can find the right reference material quickly.
Lyophilised peptides ship as complete reconstitution kits: a 1 + 1 kit pairs one lyophilized peptide vial with one sterile 3 mL reconstitution diluent vial (0.9% BA), and a 5 + 5 kit holds five of each in a moulded tray. Freeze-dried peptides are stable at −20 °C; once reconstituted, keep them at 2–8 °C. Our reconstitution calculator on every product page converts vial mass and diluent volume into an exact concentration.
Freeze-drying removes water from the peptide under vacuum, leaving a porous cake that resists hydrolysis, deamidation and oxidation far better than any solution. Sealed lyophilized vials tolerate normal transit and keep longest at −20 °C, protected from light. Each kit pairs the cake with a sterile reconstitution diluent (0.9% BA) so a stock solution can be prepared at the bench; once reconstituted, keep it at 2–8 °C and divide longer studies into single-use aliquots.
Each vial carries a unique micro-QR code linked to its lot record. Scan it to confirm authenticity, view the lot's Certificate of Analysis and check its verification key. Products are not intended for human consumption, diagnosis or treatment.
All products are for laboratory research use only. Not for human or veterinary use.
Explore our verified research catalog below. Create a researcher account to access order tracking, the Virtual Lab Fridge, and Beligas Rewards.
Most-ordered research peptides over the last 30 days.
Buffered laboratory-grade Nicotinamide Adenine Dinucleotide coenzyme for sirtuin and PARP1 assays.
Trans-3-hexenoic acid-modified GHRH (1-44) analog for pulsatile somatotropic axis research.
Dual GIP and GLP-1 receptor agonist peptide for in-vitro incretin pathway investigations.
Triple receptor agonist (GLP-1 / GIP / GCGR) reference peptide for metabolic signalling research.
Research stacks built from our most-ordered peptides in each area.
GLP-3R, GLP-1T, GLP-1S, GLP-1C, 5-Amino-1MQ, AOD-9604 and MOTS-c for metabolic research.
Selective membrane-permeable NNMT inhibitor standard for adipocyte NAD+ salvage research.
C-terminal hGH fragment (177-191) analog for lipolytic pathway and cartilage assays.
Long-acting acylated amylin analog reference standard for satiety and DACRA receptor studies.
Selective GLP-1 receptor agonist polypeptide standard for cellular metabolic assays.
Dual GIP and GLP-1 receptor agonist peptide for in-vitro incretin pathway investigations.
30 mg laboratory reference kit for dual incretin receptor binding and signalling studies.
Triple receptor agonist (GLP-1 / GIP / GCGR) reference peptide for metabolic signalling research.
High-concentration triple agonist reference standard supplied with sterile reconstitution diluent.
Mitochondrial-derived 16-amino-acid peptide regulating AMPK and Folate-AICAR pathways.
BPC-157, TB-500, ARA-290 and KPV for tissue-repair and inflammation models.
Erythropoietin-derived innate repair receptor (IRR) agonist peptide for neuro-inflammatory models.
Synthetic pentadecapeptide standard for angiogenesis, VEGFR2 expression, and fibroblast migration assays.
Alpha-MSH C-terminal tripeptide (Lys-Pro-Val) for NF-kB and melanocortin inflammatory signalling.
Actin-sequestering polypeptide reference material for cell motility and dermal repair studies.
Sermorelin, CJC-1295, ipamorelin, tesamorelin and IGF-1 LR3 for growth-hormone axis research.
Tetrasubstituted 29-amino-acid GHRH analog designed for clean episodic receptor stimulation.
83-amino-acid Long Arg3 Insulin-like Growth Factor-1 analog with reduced IGFBP binding affinity.
Selective pentapeptide ghrelin mimetic and GHS-R1a agonist without off-target ACTH/cortisol spillover.
Synthetic 29-residue GHRH fragment representing the bioactive N-terminal pituitary binding domain.
Trans-3-hexenoic acid-modified GHRH (1-44) analog for pulsatile somatotropic axis research.
NAD+, epitalon, glutathione and Khavinson-type bioregulator peptides.
Synthetic pineal tetrapeptide (Ala-Glu-Asp-Gly) standard for telomerase activity and chromatin studies.
High-purity tripeptide antioxidant reference standard for cellular redox and oxidative stress models.
Buffered laboratory-grade Nicotinamide Adenine Dinucleotide coenzyme for sirtuin and PARP1 assays.
Semax, Selank, Adamax and Pinealon for neuroscience research.
N-acetylated adamantyl-modified Semax derivative for enhanced blood-brain barrier receptor models.
Synthetic tuftsin-derived heptapeptide analog for GABAergic modulation and enkephalinase studies.
Heptapeptide ACTH (4-10) analog (Met-Glu-His-Phe-Pro-Gly-Pro) for BDNF and neurotrophic factor assays.
GHK-Cu, AHK-Cu, melanotan 2 and LL-37 for dermal and pigmentation models.
Alanyl-L-histidyl-L-lysine copper(II) tripeptide reference standard for dermal papilla and VEGF assays.
Glycyl-L-histidyl-L-lysine copper(II) complex for collagen gene expression and dermal remodeling research.
Cyclic heptapeptide melanocortin receptor (MC1R/MC4R) agonist for melanogenesis signalling studies.
Oxytocin, kisspeptin-10, hCG, PT-141 and other hormone-axis peptides.
Cyclic lactam heptapeptide MC3R/MC4R agonist reference standard for central melanocortin research.
Pre-combined multi-peptide research blends such as BPC-157 + TB-500 and CJC-1295 + ipamorelin.
Co-lyophilized 1:1 synergistic tissue regeneration blend combining BPC-157 (5 mg) and TB-500 (5 mg).
Dual GHRH + GHRP receptor synergy formulation (5 mg Mod GRF 1-29 + 5 mg Ipamorelin) in one vial.
Combined 1:1 amylin analog (5 mg) and GLP-1 agonist (5 mg) reference complex for dual-pathway assays.